The release of the dye (Evans blue) occurs due the ability of IgE to induce a local increase in vascular permeability, a “gatekeeper” IgE effect that can also be exploited to facilitate tumor targeting of other therapeutic agents that would better penetrate the tumor microenvironment due the increase in the tumor blood vessel permeability [21]. Here, IGHE is linked to neoplasm.